Loading Wockhardt…
| ₹ Cr | Jun 2026 | Mar 2026 | Dec 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Revenue | 929 | 965 | 888 | 738 | 743 |
| Operating profit | 133 | 143 | 108 | 45 | 26 |
| Operating margin | 14.3% | 14.8% | 12.2% | 6.1% | 3.5% |
| Net profit | 106 | 166 | 59 | -90 | -25 |
| Net margin | 11.4% | 17.2% | 6.6% | -12.2% | -3.4% |
| EPS (₹) | 6.55 | 10.22 | 3.61 | -5.53 | -1.57 |
Quarters are labelled by period end.
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | 3,317 | 2,915 | 2,789 | 2,646 |
| Operating profit | 403 | 180 | -53 | -149 |
| Operating margin | 12.1% | 6.2% | -1.9% | -5.6% |
| Net profit | 213 | -47 | -463 | -559 |
| Net margin | 6.4% | -1.6% | -16.6% | -21.1% |
| EPS (₹) | 13.10 | -3.02 | -32.05 | -38.79 |
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Total assets | 8,615 | 8,135 | 7,649 | 7,683 |
| Total liabilities | 3,334 | 3,478 | 3,987 | 4,021 |
| Shareholders’ equity | 4,940 | 4,353 | 3,359 | 3,354 |
| Total debt | 2,233 | 2,021 | 2,356 | 2,184 |
| Cash & equivalents | 217 | 112 | 505 | 90 |
| Debt / equity | 0.45 | 0.46 | 0.70 | 0.65 |
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Operating cash flow | 390 | -22 | 219 | 153 |
| Capital expenditure | -364 | -365 | -216 | -209 |
| Free cash flow | 26 | -387 | 3 | -56 |
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Return on equity | 4.3% | -1.1% | -13.8% | -16.7% |
| Return on assets | 2.5% | -0.6% | -6.1% | -7.3% |
| Net margin | 6.4% | -1.6% | -16.6% | -21.1% |
Source: Yahoo Finance. Figures in ₹ crore unless stated.
No analyst data available for WOCKPHARMA. Finnhub coverage is limited for some India-listed stocks.